Back to search

Article

The epigenetic eraser LSD1 lies at the apex of a reversible erythroid to myeloid cell fate decision

2021-01-14

Abstract excerpt

H3K4Me demethylase KDM1a/LSD1 is a therapeutic target for multiple diseases, including the β-globinopathies (sickle cell disease and β-thalassemia) since its inactivation has been shown to lead to robust induction of the fetal globin genes. Here we examined the consequences of conditional inactivation of Lsd1 in adult red blood cells using a new Gata1 creERT2 BAC transgene. Loss of Lsd1 activity in mice blocke...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
236f43ed-190c-5711-b0a7-287d5a959eb4
DOI
10.1101/2021.01.13.426552
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The epigenetic eraser LSD1 lies at the apex of a reversible erythroid to myeloid cell fate decisionDOI 10.1101/2021.01.13.426552
Select a neighboring publication to make it the new centre.